Oh, joyous day! The CDC has bestowed upon us the groundbreaking revelation that lower extremity pain is a big deal in adults. Who would’ve thought, right? But fear not, for the world of medicine has not left us to wallow in our misery. Enter the shining knight: Peripheral Nerve Stimulation (PNS), ready to save us from the dragon of chronic leg pain. This study, in its infinite wisdom, has decided to explore the magical realms of PNS and its valiant battles against the forces of pain in the lower extremities.

Now, hold onto your seats, because the evidence we’ve got ranges from levels II to V according to the Oxford Centre of Level of Evidence. Yes, you read that right. We’re not just talking about hearsay and old wives’ tales; we’ve got some semi-solid proof that PNS might just be the hero we’ve been waiting for. It’s been out there, fighting the good fight against pain scores, opioid use, and the ever-elusive “quality of life” measures. And guess what? It’s been targeting the sciatic and femoral nerves like a marksman, with post-amputation pain and CRPS in its crosshairs.

So, what’s the takeaway from this epic saga? PNS is not just a one-trick pony. Oh no, it’s a versatile warrior, effective against a plethora of nociceptive and neuropathic villains in the lower extremity. For chronic pain physicians, it’s like having Excalibur in their arsenal for the multi-modal management of lower limb chronic pain. So, let’s give a round of applause for PNS, the unsung hero in the quest against lower extremity pain. Bravo!